Capricor Therapeutics
CAPR
#7984
Rank
S$0.37 B
Marketcap
S$8.24
Share price
-4.36%
Change (1 day)
-59.24%
Change (1 year)

Capricor Therapeutics (CAPR) - Cash on Hand

Cash on Hand as of September 2025 : S$0.12 Billion

According to Capricor Therapeutics 's latest financial reports the company has S$0.12 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Capricor Therapeutics - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.20 B294.91%
2023-12-31S$52.15 M-6.08%
2022-12-31S$55.52 M17.74%
2021-12-31S$47.16 M9.13%
2020-12-31S$43.21 M224.26%
2019-12-31S$13.32 M34.44%
2018-12-31S$9.91 M-47.53%
2017-12-31S$18.89 M-19.4%
2016-12-31S$23.43 M22.13%
2015-12-31S$19.19 M80.77%
2014-12-31S$10.61 M307.56%
2013-12-31S$2.6 M-51.18%
2012-12-31S$5.33 M296.44%
2011-12-31S$1.34 M-69.07%
2010-12-31S$4.35 M-2.4%
2009-12-31S$4.45 M-43.33%
2008-12-31S$7.86 M-66.32%
2007-12-31S$23.35 M
2005-12-31S$0 M-54.84%
2004-12-31S$0 M-43.49%
2003-12-31S$0 M4126.08%
2002-12-31S$0 M-84.98%
2001-12-31S$0 M-98.74%
2000-12-31S$0.02 M
1999-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Cytokinetics
CYTK
S$1.24 B 876.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S$3.26 M-97.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$24.04 B 18,732.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$1.44 B 1,031.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$0.75 B 491.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$3.94 M-96.91%๐Ÿ‡บ๐Ÿ‡ธ USA